title: The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia.
abstract: Endoscopic surgical treatment has become an option to treat benign prostate hyperplasia. We evaluated the safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients. We evaluated preoperative and perioperative parameters, functional outcomes, and adverse events up to 12 months postoperatively of patients on oral anticoagulation therapy undergoing PVP, and compared the results with patients who did not take anticoagulation therapy. A total of 89 patients who received photoselective vaporization laser for benign prostate hyperplasia from May 2006 to February 2011 in our hospital were enrolled in our study. The patients were divided into two groups based on whether or not they were taking oral aspirin; 23 (25.8%) patients were taking aspirin derivatives (aspirin group), and 66 (74.2%) were not taking aspirin derivatives (control group). The mean prostate volume (58.8 mL vs 51 mL; P = 0.16) and mean energy consumption (235,268 J vs 289,793 J; P = 0.097) were comparable between the aspirin group and control group. The average postoperative results of hemoglobin were 13.4 mg/ dL for the aspirin group versus 13.9 mg/dL for the control group (P = 0.327). A significantly higher maximum flow rates and 80% improved post-void residual urine were noted during the followup. Postoperatively all variable showed significant improvement starting at month 1 of followup and remained improved for the 12 month followup. Postoperative complications were low and comparable between groups. PVP was characterized by excellent hemostatic properties and a very low intraoperative complication rate, even in the patients who were taking aspirin. On the basis of our perioperative results, we recommend PVP as a safe and effective procedure for patients with symptomatic benign prostate hyperplasia when taking an aspirin derivative.
authors: Department of Urology, Chang Gung Memorial Hospital-Linko and Chang Gung University College of Medicine, Taiwan, Republic of China.
authors: I-Hung
authors: IH
authors: Shao
authors: Chen-Pang
authors: CP
authors: Hou
authors: Shao-Ming
authors: SM
authors: Chen
authors: Chien-Lun
authors: CL
authors: Chen
authors: Yu-Hsiang
authors: YH
authors: Lin
authors: Phei-Lang
authors: PL
authors: Chang
authors: Ke-Hung
authors: KH
authors: Tsui
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage*; D006801:Humans; D017075:Laser Coagulation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D001241:Aspirin
keywords: benign prostatic hyperplasia; elderly; green light laser; laser; prostate gland
references: Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):246-55
references: 14592854
references: BJU Int. 2010 Aug;106(3):368-72
references: 19912204
references: N Engl J Med. 2006 Sep 21;355(12):1233-43
references: 16990386
references: Korean J Urol. 2011 Mar;52(3):178-83
references: 21461281
references: J Urol. 2008 Jul;180(1):241-5; discussion 245
references: 18499180
references: N Engl J Med. 1983 Aug 18;309(7):396-403
references: 6135989
references: Eur Urol. 2006 Nov;50(5):969-79; discussion 980
references: 16469429
references: J Urol. 2004 Jun;171(6 Pt 1):2502-4
references: 15126885
references: Chest. 2001 Jan;119(1 Suppl):39S-63S
references: 11157642
references: J Urol. 2008 Dec;180(6):2675-80
references: 18951570
references: Med Sci Monit. 2008 Jul;14(7):RA94-102
references: 18591930
references: BJU Int. 2009 Mar;103(6):770-5
references: 18990158
references: Lancet. 1967 Sep 2;2(7514):495-7
references: 4166411
references: J Urol. 1989 Feb;141(2):243-7
references: 2643719
references: J Urol. 2011 Sep;186(3):977-81
references: 21791350